Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:VBLT

Vascular Biogenics (VBLT) Stock Price, News & Analysis

Vascular Biogenics logo

About Vascular Biogenics Stock (NASDAQ:VBLT)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
$0.16
$5.46
52-Week Range
N/A
Volume
161,505 shs
Average Volume
2.19 million shs
Market Capitalization
$423.91 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive VBLT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Vascular Biogenics and its competitors with MarketBeat's FREE daily newsletter.

VBLT Stock News Headlines

Banks aren’t ready for this altcoin—are you?
I've never been more confident about a DeFi opportunity. This isn't about complex trading or risky bets. This is about being in the right place at the right time – and I believe that time is now.
Notable Labs Closes Merger Transaction With VBL Therapeutics
Vascular Biogenics Rises on Presentation Hype
See More Headlines

VBLT Stock Analysis - Frequently Asked Questions

Vascular Biogenics Ltd. (NASDAQ:VBLT) issued its quarterly earnings data on Monday, November, 15th. The biopharmaceutical company reported ($0.09) EPS for the quarter, topping the consensus estimate of ($0.11) by $0.02. The biopharmaceutical company had revenue of $0.20 million for the quarter, compared to analyst estimates of $0.20 million.

Based on aggregate information from My MarketBeat watchlists, some other companies that Vascular Biogenics investors own include T2 Biosystems (TTOO), SCYNEXIS (SCYX), Onconova Therapeutics (ONTX), OPKO Health (OPK), VBI Vaccines (VBIV), TherapeuticsMD (TXMD) and VAXART (VXRT).

Company Calendar

Last Earnings
11/15/2021
Today
7/03/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:VBLT
Previous Symbol
NASDAQ:VBLX
Employees
7
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$32.30 million
Pretax Margin
-3,317.05%

Debt

Sales & Book Value

Annual Sales
$660 thousand
Price / Cash Flow
N/A
Book Value
$0.32 per share
Price / Book
N/A

Miscellaneous

Free Float
72,881,000
Market Cap
$423.91 million
Optionable
Optionable
Beta
0.77

Social Links

Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

This page (NASDAQ:VBLT) was last updated on 7/3/2025 by MarketBeat.com Staff
From Our Partners